Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia - Ravandi, F; O’Brien, S M; Cortes, J E (Cancer, 2015)